EAACI Congress 2024
BackFT 18 - Flash talks on Allergen Immunotherapy 2
Sunday 02 Jun, 13:15 PM -
14:45 PM Valencia, Spain
Cordoba
Flash Talks
13:15
Development and implementation of an intelligence platform for management of allergen immunotherapy in China
13:15
IgG-Epitope Mapping of Birch-Pollen Bet v 1 Allergen in Allergic and Treated Patients for the Design of Hypoallergenic Immunotherapy Allergens
13:22
Potential impact of Der p 23 monosensitization on inmunotherapy indication
13:29
ANG-101, a new, First-in-Class plant-derived Fel d 1 biologic is clinically safe and hypoallergenic in adult cat allergic subjects
13:36
Impact of different prophylactic sublingual immunotherapy regimes on peanut allergy prevention in Brown Norway rats
13:43
Systematic literature review and adjusted indirect treatment comparisons of 2 allergen immunotherapy treatments for grass pollen–induced allergic rhinitis
13:50
Mite quantification and identification by Real Time PCR in pharmaceutical cultures
13:57
Criteria used by health professionals on the selection of allergen immunotherapy in real clinical practice. CHOICE project results from Interim analysis 2023: DOCTOR’S RESULTS
14:04
Allergen Immunotherapy decreases biologicals use in allergic rhinitis with chronic rhinosinusitis with nasal polyps (CRSwNP)
14:11
Differential study of whole genome expression profiles of peripheral blood mononuclear cells in children with dust mite specific immunotherapy for asthma
14:18
Unveiling patient profiles in the respiratory allergy care pathway
